Across TCGA pan-cancer cohorts, LINC01921 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC01921 data layer compared with 8 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC01921 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01921 expression acts as an unfavorable survival marker.

UCEC are the cancer types where LINC01921 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	0.061	0.588	.018	12	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: LINC01921 tumor-vs-normal RNA expression · all LINC01921 data types